Effect of biofeedback and deep oscillation on Raynaud's phenomenon secondary to systemic sclerosis: results of a controlled prospective randomized clinical trial.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Springer International Country of Publication: Germany NLM ID: 8206885 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-160X (Electronic) Linking ISSN: 01728172 NLM ISO Abbreviation: Rheumatol Int Subsets: MEDLINE
    • Publication Information:
      Original Publication: [Berlin ; New York, NY] : Springer International, c1981-
    • Subject Terms:
      Biofeedback, Psychology* ; Magnetic Field Therapy* ; Physical Therapy Modalities*; Raynaud Disease/*therapy ; Scleroderma, Systemic/*therapy; Adult ; Aged ; Analysis of Variance ; Chi-Square Distribution ; Female ; Germany ; Humans ; Linear Models ; Male ; Middle Aged ; Prospective Studies ; Raynaud Disease/diagnosis ; Raynaud Disease/etiology ; Scleroderma, Systemic/complications ; Scleroderma, Systemic/diagnosis ; Severity of Illness Index ; Time Factors ; Treatment Outcome
    • Abstract:
      Our aim was to evaluate the effect of deep oscillation and biofeedback on Raynaud's phenomenon (RP) secondary to systemic sclerosis (SSc). A prospective randomized study was performed in SSc patients receiving either deep oscillation (n = 10) or biofeedback (n = 8) thrice a week for 4 weeks, or patients were randomized into the waiting group untreated for vasculopathy (n = 10) in time of running the study interventions. Biofeedback resulted in an improvement of RP as determined by score reduction of visual analogue scale compared with patients of the control group (P < 0.05), whereas deep oscillation revealed a tendency for improvement (P = 0.055). The study underlines the beneficial role of physiotherapy for the treatment of SSc-related RP.
    • References:
      J Behav Med. 1984 Dec;7(4):343-53. (PMID: 6520866)
      J Invest Dermatol. 2005 Dec;125(6):1313-6. (PMID: 16354204)
      J Rehabil Med. 2008 Aug;40(8):645-50. (PMID: 19020698)
      Rheumatology (Oxford). 2009 Jul;48(7):791-5. (PMID: 19433434)
      Rheumatology (Oxford). 2006 Oct;45 Suppl 3:iii49-51. (PMID: 16987836)
      J Rheumatol. 1985 Feb;12(1):90-3. (PMID: 3981523)
      Rheumatology (Oxford). 2006 Oct;45 Suppl 3:iii33-5. (PMID: 16987831)
      J Rheumatol. 1983 Feb;10(1):167-8. (PMID: 6842480)
      Rheum Dis Clin North Am. 1996 Nov;22(4):675-94. (PMID: 8923590)
    • Molecular Sequence:
      ClinicalTrials.gov NCT00946738
    • Publication Date:
      Date Created: 20110409 Date Completed: 20120821 Latest Revision: 20211020
    • Publication Date:
      20240829
    • Accession Number:
      10.1007/s00296-011-1882-2
    • Accession Number:
      21476099